Menu
Enrolling by invitation NCT07359573

The Effect of a Passive Hip Exoskeleton on Daily-life Fatigue in Older Adults

No phase Interventional Fatigue Older Adults (65 Years and Older)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Performance test, Exoband.
Who it may be relevant to
Registry conditions: Fatigue, Older Adults (65 Years and Older). Basic parameters: from 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Belgium
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Evaluating and Monitoring Physical Fatigue While Performing Functional Activities

Overview

This crossover study investigates whether a passive lower-limb exoskeleton (Exoband) can reduce perceived exertion during everyday mobility tasks in older adults. Participants complete the fatigue protocol- a structured sequence of daily challenging tasks (e.g., overground walking, stair and slope walking, obstacle avoidance)-once with the Exoband and once without it, in randomized order and separated by a one-week washout period. During each session, distance covered until fatigue, rate of perceived exertion, physiological and gait parameters are recorded. The aim is to determine whether exoskeleton assistance enhances mobility performance and reduces functional fatigue across older adults.

Interventions

  • Other Performance test
    The participant will be asked to execute a protocol in the movement lab that induces progressive feelings of fatigue. This protocol includes a sequence of relevant functional activities, such as stair walking, slope walking, crouching, walking different path shapes. During this execution the Ratings of Perceived Exertion will be questioned, and simultaneously physiological and movement data will be collected.
  • Device Exoband
    The participant will wear the Exoband (Moveo), which is a lightweight, soft wearable exoskeleton designed to assist walking by providing elastic support to the hip during gait. It uses passive elastic elements to store and release energy in sync with the user's movement, reducing muscular effort without motors or batteries. The system is unobtrusive and aims to support mobility while preserving natural movement patterns.

Primary outcome measures

  • Changes in the Ratings of Perceived Exertion throughout the protocol execution [Time frame: Through study completion, an average of 1-2 weeks.]
Secondary outcome measures (6)
  • Changes in muscle activity (surface EMG) throughout the protocol execution [Time frame: Through study completion, an average of 1-2 weeks.]
  • Changes in heart rate (variability) (ECG sensors) throughout the protocol execution [Time frame: Through study completion, an average of 1-2 weeks.]
  • Changes in muscle oxygen saturation (Moxy Monitor) throughout the protocol execution [Time frame: Through study completion, an average of 1-2 weeks.]
  • Changes in electrodermal activity (Galvanic Skin Response - finger electrodes) throughout the protocol execution [Time frame: Through study completion, an average of 1-2 weeks.]
  • Changes in motion data (IMU sensors) throughout the protocol execution [Time frame: Through study completion, an average of 1-2 weeks.]
  • Changes in respiratory rate (respiratory chest band) throughout the protocol execution [Time frame: Through study completion, an average of 1-2 weeks.]

Eligibility criteria

Inclusion criteria

  • > 65 years old
  • Healthy physical condition

Exclusion criteria

  • Physical injury or disorder that doesn't allow good physical performance

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Crossover
Masking
Open label
Primary purpose
Supportive care

Study locations

Belgium · 1 center
  • Brubotics Rehabilitation Research Center — Jette

Identifiers

NCT: NCT07359573 · RevalExo_Exoband

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗